Clinical Trials Directory

Trials / Completed

CompletedNCT00137085

Ketamine Versus Fentanyl as an Adjunct to Propofol-Assisted Emergency Department Procedural Sedation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
124 (planned)
Sponsor
Queen's University · Academic / Other
Sex
All
Age
14 Years – 65 Years
Healthy volunteers
Not accepted

Summary

We, the investigators at Queen's University, propose to conduct a randomized, double-blind, feasibility trial comparing low-dose ketamine versus fentanyl as adjuncts to Emergency Department procedural sedation with propofol. The outcomes of interest will be safety, with respect to hemodynamic and respiratory adverse effects, as well as efficacy, with respect to adequacy of sedation and analgesia, recovery profiles and patient/physician satisfaction. Our hypothesis, based on a review of existing anesthesia literature, is that low-dose ketamine may be a safer and more efficacious alternative to fentanyl when used as an adjunct to propofol-assisted procedural sedation.

Detailed description

This initial, single-centre feasibility study will have the following specific objectives: * Comparison of low-dose ketamine with fentanyl as adjunct to propofol-assisted emergency department procedural sedation, with respect to safety and efficacy parameters; * Pilot of a blinded emergency department sedation and analgesia protocol, including drug doses, concealment techniques, and data collection tools, to determine the feasibility of a subsequent larger, multi-centre trial; * Determination of the true incidence of the primary outcome measures in the study population, using the study drug administration doses and protocol, such that an accurate sample size may be estimated for a future, adequately-powered, multi-centre trial; * Validation of a newly-developed ordered, categorical rating scale for the reporting of respiratory and hemodynamic adverse events occurring during emergency department procedural sedation and analgesia.

Conditions

Interventions

TypeNameDescription
DRUGketamine

Timeline

Start date
2004-09-01
Completion
2006-08-01
First posted
2005-08-29
Last updated
2007-06-14

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00137085. Inclusion in this directory is not an endorsement.